Developing piperlongumine-directed glutathione S-transferase inhibitors by an electrophilicity-based strategy

Developing piperlongumine-directed glutathione S-transferase inhibitors by an electrophilicity-based strategy Novel non-trimethoxylphenyl piperlongumine derivatives selectively kill cancer cells Piperlongumine Inhibits Thioredoxin Reductase 1 by Targeting Selenocysteine Residues and Sensitizes Cancer Cells to Erastin Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents Synthesis and evaluation of N -heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents Therapeutic Implications of Piperlongumine Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma The promising potential of piperlongumine as an emerging therapeutics for cancer Piperlongumine B and analogs are promising and selective inhibitors for acetylcholinesterase